Behavioral characteristics and cognitive development among school age children born to women with epilepsy

Neurological Research

Volumn 37, Issue 4, 2015, Pages 295-300

  Güveli, Betül T ^a   Gürses, Candan ^b   Ataklı, Dilek ^a   Kalem, Şükriye Akça ^b   Dirican, Ahmet ^b   Bebek, Nerses ^b   Baykan, Betül ^b   Gökyiğit, Aysen ^b  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antiepileptic drugs; Cognitive behavioral development; Epilepsy; Pregnancy; Teratogenicity

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; FOLIC ACID; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ALEXANDER IQ TEST; ARTICLE; ASSESSMENT OF HUMANS; CHILD; CHILD BEHAVIOR; CLINICAL ARTICLE; COGNITION; CONNER PARENT RATING SCALE; EDUCATIONAL STATUS; EPILEPSY; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; INTERVIEW; MALE; MONOTHERAPY; MORBIDITY; PREGNANCY; PRENATAL DRUG EXPOSURE; SIBLING; TASK PERFORMANCE; TERATOGENICITY; TONIC CLONIC SEIZURE; WECHSLER INTELLIGENCE SCALE FOR THE CHILDREN REVISED TEST; CHEMICALLY INDUCED; DEVELOPMENTAL DISORDER; DRUG EFFECTS; INTELLIGENCE; PRENATAL EXPOSURE; PSYCHOLOGY;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD BEHAVIOR; COGNITION; DEVELOPMENTAL DISABILITIES; EPILEPSY; FEMALE; HUMANS; INTELLIGENCE; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84921780767     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132814Y.0000000449     Document Type: Article

References (40)

1. Epilepsy Guidelines Group. Primary Care guidelines for the management of females with epilepsy. London: Royal Society of Medicine Press Ltd; 2004.
2. Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth JA, Wiebe S, et al. Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: report of the quality standards subcommittee and therapeutics subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2009;50:1237-46.
3. Tomson T, Battino D, French J, Harden C, Holmes L, Morrow J, et al. Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries. Epilepsy Behav. 2007;11:277-82.
4. Vajda FJ, Hitchcock A, Graham J, O'Brien T, Lander C, Eadie M. The Australian register of antiepileptic drugs in pregnancy: the first 1002 pregnancies. Aust NZ J Obstetr Gynaecol. 2007;47:468-74.
5. Mawer G, Briggs M, Baker GA, Bromley R, Coyle H, Eatock J, et al. Liverpool & Manchester Neurodevelopment Group. Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure. 2010;19:112-9.
6. Bromley RL, Mawer G, Love J, Kelly J, Purdy L, McEwan L, et al. On behalf of the Liverpool and Manchester Neurodevelopment Group. Early cognitive development in children born to women with epilepsy: a prospective report. Epilepsia. 2010;51:2058-65.
7. Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2004;75:1575-83.
8. Gaily E, Kantola-Sorsa E, Hiilesmaa V, Isoaho M, Matila R, Kotila M, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology. 2004;62;28-32.
9. Kantola-Sorsa E, Gaily E, Isoaho M, Korkman M. Neuropsychological outcomes in children of mothers with epilepsy. J Int Neuropsychol Soc. 2007;13:642-52.
10. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs- Cantrell DT, Cohen M, et al.; NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360:1597-605.
11. Bromley RL, Mawer G, Clayton-Smith J, Baker GA, The Liverpool and Manchester Neurodevelopment Group. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology. 2008;71:1923-24.
12. Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. JMed Genet. 2002;39:251-9.
13. Berg AT, Berkovic SF, Brodie JM, Buchhalter J, Cross JH, Boas WE, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010:51;676-85.
14. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Cohen MJ, Kalayjian LA, et al. Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure. Epilepsy Behav. 2011;21:147-52.
15. Eriksson K, Viinikainen K, Mönkkönen A, Äikia M, Nieminen P, Heinonen S, et al. Children exposed to valproate in utero - population based evaluation of risks and confounding factors for long-term neurocognitive development Epilepsy Res. 2005;65:189-200.
16. Hirano T, Fujioka K, Okada M, Iwasa H, Kaneko S. Physical and psychomotor development in the offspring born to mothers with epilepsy. Epilepsia. 2004;45(Suppl 8):53-7.
17. Forsberg L, Wide K, Källe'n B. School performance at age 16 in children exposed to antiepileptic drugs in utero - a population-based study. Epilepsia. 2011;52:364-9.
18. Adams J, Vorhees CV, Middaugh LD. Developmental neurotoxicity of anticonvulsants: human and animal evidence on phenytoin. Neurotoxicol Teratol. 1990;12:203-14.
19. Fisher JE, Vorhees C. Developmental toxicity of antiepileptic drugs: relationship to postnatal dysfunction. Pharmacol Res. 1992;26:207-21.
20. Costa LG, Steardo L, Cuomo V. Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects. Pharmacol Rev. 2004;56:103-47.
21. Frieder B, Epstein S, Grimm VE. The effects of exposure to diazepam during various stages of gestation or during lactation on the development and behavior of rat pups. Psychopharmacology (Berl). 1984;83:51-5.
22. Phillips NK, Lockard JS. Infant monkey hyperexcitability after prenatal exposure to antiepileptic compounds. Epilepsia. 1996;37:991-9.
23. Diaz J, Schain RJ, Bailey BG. Phenobarbital-induced brain growth retardation in artificially reared rat pups. Biol Neonate. 1977;32:77-82.
24. Fishman RH, Gaathon A, Yanai J. Early barbiturate treatment eliminates peak serum thyroxide levels in neonatal mice and produces ultrastructural damage in brain of adults. Dev Brain Res. 1982;5:202-5.
25. Yanai J, Fares F, Gavish M, Greenfeld Z, Katz Y, Marcovici G, et al. Neural and behavioral alterations after early exposure to phenobarbital. Neurotoxicology. 1989;10:543-54.
26. Tachibana T, Terada Y, Fukunishi K, Tanimura T. Estimated magnitude of behavioral effects of phenytoin in rats and its reproducibility: a collaborative behavioral teratology study in Japan. Physiol Behav. 1996;60:941-52.
27. Hatta T, Ohmori H, Murakami T, Takano M, Yamashita K, Yasuda M. Neurotoxic effects of phenytoin on postnatal mouse brain development following neonatal administration. Neurotoxicol Teratol. 1999;21:21-8.
28. Vorhees CV, Rauch SL, Hitzemann RJ. Prenatal phenytoin exposure decreases neuronal membrane order in rat offspring hippocampus. Int J Dev Neurosci. 1990;8:283-8.
29. Bennett GD, Lau F, Calvin JA, Finnell RH. Phenytoin-induced teratogenesis: a molecular basis for the observed developmental delay during neurulation. Epilepsia. 1997;38:415-23.
30. Elmazar MM, Sullivan FM. Effect of prenatal phenytoin administration on postnatal development of the rat: a behavioral teratology study. Teratology. 1981;24:115-24.
31. Weisenburger WP, Minck DR, Acuff KD, Vorhees CV. Dose- response effects of prenatal phenytoin exposure in rats: effects on early locomotion, maze learning, and memory as a function of phenytoin-induced circling behavior. Neurotoxicol Teratol. 1990;12:145-52.
32. Vorhees CV. Fetal hydantoin syndrome in rats: dose-effect relationships of prenatal phenytoin on postnatal development and behavior. Teratology. 1987;35:287-303.
33. Pizzi WJ, Alexander TD, Loftus JT. Developmental and behavioral effects of prenatal primidone exposure in the rat. Pharm Biochem Behav. 1996;55:481-7.
34. Vorhees CV, Rauch SL, Hitzemann RJ. Prenatal valproic acid exposure decreases neuronal membrane order in rat offspring hippocampus and cortex. Neurotoxicol Teratol. 1991;13:471-4.
35. Thurston JH, Hauhart RE, Schulz DW, Naccarato EF, Dodson WE, Carroll JE. Chronic valproate administration produces hepatic dysfunction and may delay brain maturation in infant mice. Neurology. 1981;31:1063-9.
36. Vorhees CV. Behavioral teratogenicity of valproic acid: selective effects on behavior after prenatal exposure to rats. Psychopharmacology. 1987;92:173-9.
37. Vorhees CV. Teratogenicity and developmental toxicity of valproic acid. Teratology. 1987;35:195-202.
38. Nadebaum C, Anderson V, Vajda F, Reutens D, Barton S,Wood A. The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy. J Int Neuropsychol Soc. 2011;17:133-42.
39. Nadebaum C, Anderson VA, Vajda F, Reutens DC, Barton S, Wood AG. Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology. 2011;76;719-26.
40. Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton- Smith J, Kalayjian LA, et al.; NEAD Study Group. Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain. 2011;134:396-404.